Overcoming resistance to EGFR inhibitors in EGFR mutant NSCLC /
Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC presents updated information on how EGFR mutant lung cancers evolve to evade EGFR inhibitors, clinical strategies that identify these mechanisms, and how to implement newer therapeutic strategies to combat resistance and improve patient s...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
London ; San Diego, CA :
Academic Press, an imprint of Elsevier,
[2023]
|
| Series: | Cancer sensitizing agents for chemotherapy ;
v. 19. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Internet
Connect to the full text of this electronic bookAvailable Online
| Call Number: |
RC280.L8 O84 2023 |
|
|---|---|---|
| Call Number | Status | Get It |
| RC280.L8 O84 2023 | Available | |